|
WO02102264A1
|
|
Depilation
|
|
ZA200202778B
|
|
Compositions and methods for L-nucleosides, L-nucleotides, and their analogs.
|
|
HU0301730A2
|
|
Nucleoside compounds and uses thereof
|
|
PL365239A1
|
|
Nucleoside analogs with carboxamidine-modified bicyclic base
|
|
CN1817349A
|
|
Nucleoside analogues with carboxamidine-modified monocyclic base
|
|
EP1244356A1
|
|
Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
|
|
AU2281601A
|
|
Treatment of viral infections using levovirinTM
|
|
AU5076601A
|
|
Pulmonary delivery of ribavirin or levovirinTM for systemic and quasi-systemic treatment of disease
|
|
IL147908D0
|
|
PYRROLO[2,3-d] PYRIMIDINE NUCLEOSIDE ANALOGS
|
|
IL137393D0
|
|
Purine l-nucleosides, analogs and uses thereof
|
|
IL137390D0
|
|
Nucleosides
|
|
AU4865900A
|
|
Novel nucleosides
|
|
YU43500A
|
|
Purine-l-nucleosides, analogs and uses thereof
|
|
AU4513700A
|
|
Purine L-nucleosides, analogs and uses thereof
|
|
HRP20000421A2
|
|
Cytokine related treatments of disease
|
|
HRP20000423A2
|
|
Novel nucleosides
|
|
HRP20000420A2
|
|
Purine l-nucleosides, analogs and uses thereof
|
|
HRP20000422A2
|
|
Purine l-nucleosides, analogs and uses thereof
|
|
US6509320B1
|
|
Purine L-nucleosides, analogs and uses thereof
|
|
HK1052937A1
|
|
Cytokine related treatments of disease
|
